The Medicines Patent Pool is improving access to essential medication where it’s most needed, but does it make economic sense ?
17 août 2026 | Bruno Versaevel, Professor of industrial economics, EM Lyon Business School, Etienne Billette de Villemeur, Professor, Université de Lille, Vianney Dequiedt, Professor of Economics, Université Clermont Auvergne (UCA)
Three economists explore the viability of a UN-backed one-stop licensing ‘hub’ for making essential, often life-saving biotherapeutics and vaccines both affordable and more widely available.
Site référencé: The Conversation